[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2008001184A3 - Solid composition - Google Patents

Solid composition Download PDF

Info

Publication number
WO2008001184A3
WO2008001184A3 PCT/IB2007/001722 IB2007001722W WO2008001184A3 WO 2008001184 A3 WO2008001184 A3 WO 2008001184A3 IB 2007001722 W IB2007001722 W IB 2007001722W WO 2008001184 A3 WO2008001184 A3 WO 2008001184A3
Authority
WO
WIPO (PCT)
Prior art keywords
solid composition
diuretic
ace
inhibitor
oral
Prior art date
Application number
PCT/IB2007/001722
Other languages
French (fr)
Other versions
WO2008001184A2 (en
Inventor
Manjusha Ambadas Joshi
Dhanashri Manohar Kale
Satish Ramanlal Mehta
Original Assignee
Emcure Pharmaceuticals Ltd
Manjusha Ambadas Joshi
Dhanashri Manohar Kale
Satish Ramanlal Mehta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd, Manjusha Ambadas Joshi, Dhanashri Manohar Kale, Satish Ramanlal Mehta filed Critical Emcure Pharmaceuticals Ltd
Publication of WO2008001184A2 publication Critical patent/WO2008001184A2/en
Publication of WO2008001184A3 publication Critical patent/WO2008001184A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an oral, stable pharmaceutical composition of angiotensin converting enzyme (ACE) inhibitor in combination with a diuretic, and to a process for preparation thereof.
PCT/IB2007/001722 2006-06-26 2007-06-22 Solid composition WO2008001184A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN995/MUM/2006 2006-06-26
IN995MU2006 2006-06-26

Publications (2)

Publication Number Publication Date
WO2008001184A2 WO2008001184A2 (en) 2008-01-03
WO2008001184A3 true WO2008001184A3 (en) 2008-04-17

Family

ID=38695581

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/001722 WO2008001184A2 (en) 2006-06-26 2007-06-22 Solid composition

Country Status (1)

Country Link
WO (1) WO2008001184A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200906322A2 (en) 2009-08-17 2011-07-21 Bi̇lgi̇ç Mahmut Granules with improved solubility and stability properties.
ES2364011B1 (en) 2009-11-20 2013-01-24 Gp Pharm, S.A. CAPSULES OF PHARMACEUTICAL ACTIVE AND ESTERS OF POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014343A1 (en) * 2002-08-02 2004-02-19 Ranbaxy Laboratories Limited Storage stable tablets of fosinopril sodium
WO2005011586A2 (en) * 2003-07-28 2005-02-10 Dr. Reddy's Laboratories, Inc. Treatment and preventi0n of cardiovascular events
WO2005079762A1 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh Multilayer tablet
US20050202081A1 (en) * 2002-01-15 2005-09-15 Deepak Bahl Stable pharmaceutical compositions comprising ace inhibitor(s)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202081A1 (en) * 2002-01-15 2005-09-15 Deepak Bahl Stable pharmaceutical compositions comprising ace inhibitor(s)
WO2004014343A1 (en) * 2002-08-02 2004-02-19 Ranbaxy Laboratories Limited Storage stable tablets of fosinopril sodium
WO2005011586A2 (en) * 2003-07-28 2005-02-10 Dr. Reddy's Laboratories, Inc. Treatment and preventi0n of cardiovascular events
WO2005079762A1 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh Multilayer tablet

Also Published As

Publication number Publication date
WO2008001184A2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2008075081A3 (en) Composition and method for detection of demineralisation
WO2006091529A3 (en) A solid pharmaceutical dosage formulation
SG171649A1 (en) Dpp iv inhibitor formulations
WO2009082701A8 (en) Hcv protease inhibitors and uses thereof
WO2008073448A3 (en) Pharmaceutical formulations and methods for making the same
WO2007095116A3 (en) Glass compositions for protecting glass and methods of making and using thereof
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2005067893A3 (en) Pharmaceutical compositions comprising midazolam in a high concentration
WO2009004629A3 (en) A method for decreasing symptoms of alcohol consumption
WO2008053297A3 (en) Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
WO2010055119A3 (en) Pharmaceutical composition comprising pimobendan
WO2008002673A3 (en) Cell-free synthesis of virus like particles
WO2008070257A3 (en) Crystal structure of a trna synthetase
WO2006002348A3 (en) Solid and crystalline ibandronic acid
WO2008083130A3 (en) Amorphous and crystalline form a of carvedilol phosphate
WO2009004593A3 (en) Processes for the preparation of epinephrine
WO2010049449A3 (en) Novel salts of sunitinib
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2008156645A3 (en) Pharmaceutical compositions and uses
WO2005067887A3 (en) Formulations of ramipril
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
EP1637167A3 (en) New injectable formulations containing progesterone
WO2007125521A3 (en) Polymorphic form of zoledronic acid and processes for their preparation
WO2005084648A8 (en) Pharmaceutical compositions comprising candesartan cilexetil

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07766584

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07766584

Country of ref document: EP

Kind code of ref document: A2